Suivre
Anne von Maessenhausen
Anne von Maessenhausen
Medizininische Klinik III, Nephrologie, Uniklinikum Dresden
Adresse e-mail validée de ukdd.de
Titre
Citée par
Citée par
Année
Necroptosis controls NET generation and mediates complement activation, endothelial damage, and autoimmune vasculitis
A Schreiber, A Rousselle, JU Becker, A Von Mässenhausen, ...
Proceedings of the National Academy of Sciences 114 (45), E9618-E9625, 2017
2402017
TBK1 and IKKε prevent TNF-induced cell death by RIPK1 phosphorylation
E Lafont, P Draber, E Rieser, M Reichert, S Kupka, D de Miguel, ...
Nature cell biology 20 (12), 1389-1399, 2018
2242018
Viral infiltration of pancreatic islets in patients with COVID-19
C Steenblock, S Richter, I Berger, M Barovic, J Schmid, U Schubert, ...
Nature communications 12 (1), 3534, 2021
1562021
The pathological features of regulated necrosis
W Tonnus, C Meyer, A Paliege, A Belavgeni, A von Mässenhausen, ...
The Journal of pathology 247 (5), 697-707, 2019
1472019
Dysfunction of the key ferroptosis-surveilling systems hypersensitizes mice to tubular necrosis during acute kidney injury
W Tonnus, C Meyer, C Steinebach, A Belavgeni, A von Mässenhausen, ...
Nature communications 12 (1), 4402, 2021
1332021
TWEAK and RIPK1 mediate a second wave of cell death during AKI
D Martin-Sanchez, M Fontecha-Barriuso, S Carrasco, MD Sanchez-Niño, ...
Proceedings of the National Academy of Sciences 115 (16), 4182-4187, 2018
1312018
FGFR1 expression levels predict BGJ398 sensitivity of FGFR1-dependent head and neck squamous cell cancers
F Göke, A Franzen, TK Hinz, LA Marek, P Yoon, R Sharma, M Bode, ...
Clinical cancer research 21 (19), 4356-4364, 2015
982015
Pan-cancer analysis of the mediator complex transcriptome identifies CDK19 and CDK8 as therapeutic targets in advanced prostate cancer
J Brägelmann, N Klümper, A Offermann, A Von Maessenhausen, D Böhm, ...
Clinical Cancer Research 23 (7), 1829-1840, 2017
952017
Exquisite sensitivity of adrenocortical carcinomas to induction of ferroptosis
A Belavgeni, SR Bornstein, A Von Mässenhausen, W Tonnus, J Stumpf, ...
Proceedings of the National Academy of Sciences 116 (44), 22269-22274, 2019
932019
Immunological consequences of kidney cell death
M Sarhan, A von Mässenhausen, C Hugo, R Oberbauer, A Linkermann
Cell Death & Disease 9 (2), 114, 2018
802018
Assembly of methylated KDM1A and CHD1 drives androgen receptor–dependent transcription and translocation
E Metzger, D Willmann, J McMillan, I Forne, P Metzger, S Gerhardt, ...
Nature structural & molecular biology 23 (2), 132-139, 2016
792016
Phenytoin inhibits necroptosis
A Von Mässenhausen, W Tonnus, N Himmerkus, S Parmentier, D Saleh, ...
Cell death & disease 9 (3), 359, 2018
612018
Nonamplified FGFR1 is a growth driver in malignant pleural mesothelioma
LA Marek, TK Hinz, A Von Mässenhausen, KA Olszewski, EK Kleczko, ...
Molecular cancer research 12 (10), 1460-1469, 2014
512014
SETDB1 is required for intestinal epithelial differentiation and the prevention of intestinal inflammation
L Južnić, K Peuker, A Strigli, M Brosch, A Herrmann, R Häsler, M Koch, ...
Gut 70 (3), 485-498, 2021
482021
Dexamethasone sensitizes to ferroptosis by glucocorticoid receptor–induced dipeptidase-1 expression and glutathione depletion
A von Mässenhausen, N Zamora Gonzalez, F Maremonti, A Belavgeni, ...
Science advances 8 (5), eabl8920, 2022
462022
Cell death pathways drive necroinflammation during acute kidney injury
A von Mässenhausen, W Tonnus, A Linkermann
Nephron 140 (2), 144-147, 2018
432018
Fibroblast growth factor receptor 1 gene amplification in pancreatic ductal adenocarcinoma
NC Lehnen, A von Mässenhausen, H Kalthoff, H Zhou, T Glowka, ...
Histopathology 63 (2), 157-166, 2013
412013
Ecotropic viral integration site 1, a novel oncogene in prostate cancer
A Queisser, S Hagedorn, H Wang, T Schaefer, M Konantz, S Alavi, ...
Oncogene 36 (11), 1573-1584, 2017
402017
Dipeptidase-1 governs renal inflammation during ischemia reperfusion injury
A Lau, JJ Rahn, M Chappellaz, H Chung, H Benediktsson, D Bihan, ...
Science advances 8 (5), eabm0142, 2022
362022
Targeting DDR2 in head and neck squamous cell carcinoma with dasatinib
A von Mässenhausen, C Sanders, J Brägelmann, M Konantz, A Queisser, ...
International journal of cancer 139 (10), 2359-2369, 2016
362016
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20